TigaTx

TigaTx is a biotechnology company developing engineered monomeric IgA neutrophil engagers to unleash the tumor-killing capabilities of neutrophils against cancer, as well as engineered dimeric IgA for infectious disease targeting. The company’s cutting-edge approach to engineering therapeutic IgA is based on the groundbreaking work of Professor Jeanette Leusen at the University Medical Center Utrecht (Utrecht, Netherlands) and is broadly applicable to many different diseases.